SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52157 680 3 CRSP
Emcee:  Biomaven Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
51853New AI technology could shape the future of RNA therapeutics Posted: 27 SeptembFrank Sully-9/27/2021
51852Woolly mammoths could walk the Earth again by 2027 if CRISPR startup succeeds CFrank Sully-9/26/2021
51851Tomato is first CRISPR-edited food to go on sale in the world 24 September 202Frank Sully-9/26/2021
51850CRISPR Technology Global Market Report 2021: COVID-19 Growth And Change To 2030 Frank Sully19/26/2021
51849I sold my remaining shares at $14 and change after the meeting with the FDA. I A.J. Mullen19/24/2021
51848Thank you for your response.xr1-9/24/2021
51847Being a long term investor in FGEN, I have been concerned over the FDA decision Art Bechhoefer19/24/2021
51846Do we see any hope for FGEN ? Thanks for any comment. XR1xr1-9/23/2021
51845Caribou Up 9% No news I’m aware of except recent addition to Russell 2,000 CARFrank Sully-9/23/2021
51844Comparing Four AI-Powered Drug Discovery Stocks [graphic] Nanalyze [graphic] Frank Sully-9/19/2021
51843Caribou To Be Added To Russell 2000 Small Cap Index Top IPO additions to RusselFrank Sully-9/17/2021
51842AI Lab of the Future Seeks to Build a Digital Cell [graphic] Source: Wladimir Frank Sully19/15/2021
51841Neurocrine Sciences (NBIX) gets approval of a Clinical Trial Application in EuroA.J. Mullen-9/9/2021
51840Caribou Up 6.7% In Premarket Trading CRBU Caribou Biosciences, Inc. | NASDAQ 29Frank Sully-9/7/2021
51839Congress demands documents from FDA on controversial approval of Biogen’s AlzheiA.J. Mullen-9/6/2021
51838Caribou Up Another 3% After Hours CRBU Caribou Biosciences, Inc. | NASDAQ 29.9Frank Sully-9/4/2021
51837Caribou Biosciences Provides Business Update and Reports Second Quarter 2021 FinFrank Sully-9/3/2021
51836Caribou Continues To Climb - Up Another 5% CRBU Caribou Biosciences, Inc. | NASFrank Sully-9/3/2021
51835Caribou Continues To Climb CRBU Caribou Biosciences, Inc. | NASDAQ 28.56 1.58 (Frank Sully-9/2/2021
51834Bought Caribou Biosciences I bought 450 shares of Caribou Biosciences (CRBU) toFrank Sully-8/31/2021
518333 Reasons Caribou Biosciences Could Be the Best Gene-Editing Stock for Your PortFrank Sully18/31/2021
51832Genome Editing Market Report 2021 Market SWOT Analysis and Forecast 2028 | MerckFrank Sully18/31/2021
51831medical billing errors: nopatientleftbehind.org you may be thinking: &qusoftware salesperson18/26/2021
51830CRISPR Therapeutics stock on the move CRISPR THERAPEUTICS AG Stock , CRSP 125.8Frank Sully-8/23/2021
51829TRIL Been a really awful year on the biotech front, for me at least. Glad to seeFiloF-8/23/2021
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News